G2B will be attending Bio€quity Europe & Asebio Investor Day 2024
Gate2Brain will be attending Bio€quity Europe 2024 & Asebio Investor Day from the 12 to 15th May 2024, in San Sebastián, Spain.
BioEquity Europe is a collaborative gathering of the corporate investment communities for the European life sciences that will take place 12-14 May
AseBio – Asociación Española de Bioempresas Investor Day is the main biotechnology investment forum in Spain that will be held on May 15. Its main objective is to connect Spanish biotechnology companies and innovative projects seeking financing with an audience of local and international investors.
Our CEO, Meritxell Teixido and our Business Development Manager, Carles Taulé Flores, will be at both events to pitch Gate2Brain’s innovative technology platform and to strengthen our global partnerships and connect with cross-border investors and decision-makers.
Be sure to join us to learn more about Gate2Brain’s novel technology for the delivery of therapeutics across biological barriers. A platform ready for R&D and out-licensing agreements.
Together we can empower tomorrow’s solutions today. Seize the opportunity and meet us!
More information about G2B: https://gate2brain.com
Join us for a one-to-one meeting 👇
➡️ Bio€quity
https://lnkd.in/dWaS4bVH
🗣️Gate2Brain’s Pitch Presentation at Bio€quity
13 May at 16:00, Room 9
➡️ AseBio Investor Day
https://lnkd.in/dg379fNf
🗣️Gate2Brain’s Pitch Presentation at AseBio – Asociación Española de Bioempresas Inverstors Day
15 May at 10:36
📧 info@gate2brain.com
🗓️ 12-15 May
📍 San Sebastián, Spain
